Pump-controlled retrograde trial off: considerations

Adrian C Mattke^{1

2}, Anthony Black³, Prem Venugopal⁴

Affiliations

¹ 1 Lady Cilento Children's Hospital, Paediatric Critical Care Research Group, University of Queensland, South Brisbane, Queensland, Australia.
² 2 Paediatric Intensive Care Unit, Lady Cilento Children's Hospital, South Brisbane, Queensland, Australia.
³ 3 Department of Perfusion, Lady Cilento Children's Hospital, South Brisbane, Queensland, Australia.
⁴ 4 Queensland Neonatal & Pediatric ECLS Service, Brisbane, Australia.

Comment

Adrian C Mattke et al. Perfusion. 2019 Mar.

. 2019 Mar;34(2):173.

doi: 10.1177/0267659118806452. Epub 2018 Oct 5.

Adrian C Mattke^{1

2}, Anthony Black³, Prem Venugopal⁴

¹ 1 Lady Cilento Children's Hospital, Paediatric Critical Care Research Group, University of Queensland, South Brisbane, Queensland, Australia.
² 2 Paediatric Intensive Care Unit, Lady Cilento Children's Hospital, South Brisbane, Queensland, Australia.
³ 3 Department of Perfusion, Lady Cilento Children's Hospital, South Brisbane, Queensland, Australia.
⁴ 4 Queensland Neonatal & Pediatric ECLS Service, Brisbane, Australia.

No abstract available

Comment on

Weaning adult patients with cardiogenic shock on veno-arterial extracorporeal membrane oxygenation by pump-controlled retrograde trial off.
Ling L, Chan KM. Ling L, et al. Perfusion. 2018 Jul;33(5):339-345. doi: 10.1177/0267659118755888. Epub 2018 Feb 7. Perfusion. 2018. PMID: 29409389 Clinical Trial.